Last reviewed · How we verify

NCT04796363

US Guided Erector Spinae Plane Block in Breast Cancer Surgery: Analgesia, Spread and Immunomodulation

Completed NA Last updated 11 April 2022
What this trial tests

NA trial testing Erector Spinae Plane Block with Bubivacaine in Analgesia in 60 participants. Completed in 21 January 2022.

Timeline
25 November 2020
Primary endpoint
11 January 2022
21 January 2022

Quick facts

Lead sponsorAlexandria University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment60
Start date25 November 2020
Primary completion11 January 2022
Estimated completion21 January 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

Adults 20 to 50, any sex, with Analgesia or Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective interventional study

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Analgesia and spread of erector spinae plane block in breast cancer surgeries: a randomized controlled trial.
    Abdella AMMR, Arida EEAEM, Megahed NA, El-Amrawy WZ, et al · · 2022 · cited 18× · PMID 36253729 · DOI 10.1186/s12871-022-01860-w
  2. Analgesia and spread of Erector Spinae Plane Block in breast cancer surgeries: a randomized controlled trial
    Abdella A, Arida EE, Megahed N, El-Amrawy W, et al · · 2022 · DOI 10.21203/rs.3.rs-1910138/v1

Verify or expand the search:

Other recruiting trials for Analgesia

Currently open trials in the same condition.

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04796363.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing